These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14680725)

  • 21. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
    Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of preventive therapy with quinapril on IL-6 level in patients with chronic stable angina.
    Gibas M; Miszczak-Smiałek J; Madry E; Głuszek J; Witmanowski H; Piotrowski J
    Pharmacol Rep; 2007; 59(3):330-8. PubMed ID: 17652834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of quinapril on functional status of elderly patients with diastolic heart failure.
    Zi M; Carmichael N; Lye M
    Cardiovasc Drugs Ther; 2003 Mar; 17(2):133-9. PubMed ID: 12975595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of quinapril on the attenuated heart rate recovery of type 2 diabetic subjects without known coronary artery disease.
    Sipahi I; Tekin G; Yigit Z; Guzelsoy D; Guven O
    Clin Cardiol; 2004 Aug; 27(8):480-4. PubMed ID: 15346847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.
    Ikram H; Low CJ; Shirlaw TM; Foy SG; Crozier IG; Richards AM; Khurmi NS; Horsburgh RJ
    Br Heart J; 1994 Jan; 71(1):30-3. PubMed ID: 8297690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism by which quinapril improves vascular function in coronary artery disease.
    Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study).
    Anderson TJ; Elstein E; Haber H; Charbonneau F
    J Am Coll Cardiol; 2000 Jan; 35(1):60-6. PubMed ID: 10636260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome.
    Khan BV; Sola S; Lauten WB; Natarajan R; Hooper WC; Menon RG; Lerakis S; Helmy T
    Diabetes Care; 2004 Jul; 27(7):1712-5. PubMed ID: 15220251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
    Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
    Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
    Otsuka M; Yamamoto H; Okimoto T; Dohi Y; Mito S; Gomyo Y; Fujii T; Matsuura W; Hirai Y; Kohno N
    Am Heart J; 2004 Apr; 147(4):662-8. PubMed ID: 15077082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE-inhibitors in coronary artery disease?
    Vogt M; Motz W; Strauer BE
    Basic Res Cardiol; 1993; 88 Suppl 1():43-64. PubMed ID: 8357335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
    Hoshida S; Yamashita N; Kawahara K; Kuzuya T; Hori M
    Circulation; 1999 Jan; 99(3):434-40. PubMed ID: 9918532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
    Riegger GA
    Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
    Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
    Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
    Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
    Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
    MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.